Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 4
2014 2
2015 1
2016 1
2017 2
2018 2
2019 3
2020 5
2021 13
2022 13
2023 6
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
MAO Inhibitors.
Sabri MA, Saber-Ayad MM. Sabri MA, et al. Among authors: saber ayad mm. 2023 Jun 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jun 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32491327 Free Books & Documents.
The Rationale for Potential Pharmacotherapy of COVID-19.
Saber-Ayad M, Saleh MA, Abu-Gharbieh E. Saber-Ayad M, et al. Pharmaceuticals (Basel). 2020 May 14;13(5):96. doi: 10.3390/ph13050096. Pharmaceuticals (Basel). 2020. PMID: 32423024 Free PMC article. Review.
Complement System: An Immunotherapy Target in Colorectal Cancer.
Talaat IM, Elemam NM, Saber-Ayad M. Talaat IM, et al. Among authors: saber ayad m. Front Immunol. 2022 Jan 31;13:810993. doi: 10.3389/fimmu.2022.810993. eCollection 2022. Front Immunol. 2022. PMID: 35173724 Free PMC article. Review.
Editorial: Epigenetic and metabolic regulators of breast carcinogenesis.
Talaat IM, Saber-Ayad M, Busch H, Elemam NM. Talaat IM, et al. Among authors: saber ayad m. Front Oncol. 2024 Mar 28;14:1383043. doi: 10.3389/fonc.2024.1383043. eCollection 2024. Front Oncol. 2024. PMID: 38606097 Free PMC article. No abstract available.
Current Status of Baricitinib as a Repurposed Therapy for COVID-19.
Saber-Ayad M, Hammoudeh S, Abu-Gharbieh E, Hamoudi R, Tarazi H, Al-Tel TH, Hamid Q. Saber-Ayad M, et al. Pharmaceuticals (Basel). 2021 Jul 15;14(7):680. doi: 10.3390/ph14070680. Pharmaceuticals (Basel). 2021. PMID: 34358107 Free PMC article. Review.
54 results